Evidence map›Paper›PMID 32071072›Full record

ArticleeNeuro

Considerations for Clinical Therapeutic Development of Statins for Neurodevelopmental Disorders.

Myrthe J Ottenhoff, Lianne C Krab, Ype Elgersma

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Myrthe J OttenhoffDepartment of Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands.ORCID 0000-0003-1934-7752
Lianne C KrabCordaan Outpatient Clinic for ID Medicine, 1033 PK, Amsterdam.ORCID 0000-0002-2480-2011
Ype ElgersmaDepartment of Neuroscience, ENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus Medical Center, 3015 GD, Rotterdam, The Netherlands y.elgersma@erasmusmc.nl.ORCID 0000-0002-3758-1297
Erasmus MC · NLAmsterdam Neuroscience · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsNeurodevelopmental DisordersHumansLovastatinSimvastatinHydroxymethylglutaryl-CoA Reductase InhibitorsLovastatinSimvastatinautism spectrum disordercognitive trialsfragile Xlovastatin, RASopathiessimvastatin

Identifiers

PMID32071072
PMCPMC7070444
OpenAlexW3007330152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.